DIAPHRAGM NEOPLASM

This adverse event was reported 23 times

DIAPHRAGM NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GLOFITAMAB 1 0.0004
1 AMOXICILLIN AND CLAVULANATE POTASSIUM 1 0.0002
2 DACARBAZINE 1 0.0001
3 BLEOMYCIN SULFATE 1 0.0001
4 SENNOSIDES 8.6 MG TABLETS 1 0.0000
5 NIRAPARIB 1 0.0000
6 ELTROMBOPAG OLAMINE 1 0.0000
7 SENNA LEAF 1 0.0000
8 IMATINIB MESYLATE 1 0.0000
9 ERGOCALCIFEROL 1 0.0000
See all drugs enriched for association with DIAPHRAGM NEOPLASM

DIAPHRAGM NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
1 Provitamin D2 Compound [EPC] 1 0.0000
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Aromatase Inhibitor [EPC] 1 0.0000
4 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
5 Opioid Agonist [EPC] 2 0.0000
6 Platinum-based Drug [EPC] 2 0.0000
7 Janus Kinase Inhibitor [EPC] 1 0.0000
8 Expectorant [EPC] 1 0.0000
9 Thiazide Diuretic [EPC] 1 0.0000
See all drug classes enriched for association with DIAPHRAGM NEOPLASM